KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Asset Utilization Ratio (2016 - 2026)

Pacira BioSciences has reported Asset Utilization Ratio over the past 16 years, most recently at 0.59 for Q1 2026.

  • For Q1 2026, Asset Utilization Ratio rose 32.75% year-over-year to 0.59; the TTM value through Mar 2026 reached 0.59, up 32.75%, while the annual FY2025 figure was 0.52, 15.01% up from the prior year.
  • Asset Utilization Ratio for Q1 2026 was 0.59 at Pacira BioSciences, up from 0.57 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.59 in Q1 2026 and troughed at 0.01 in Q4 2022.
  • A 5-year average of 0.34 and a median of 0.43 in 2024 define the central range for Asset Utilization Ratio.
  • On a YoY basis, Asset Utilization Ratio climbed as much as 4760.21% in 2023 and fell as far as 97.57% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.01 in 2022, then soared by 4760.21% to 0.43 in 2023, then increased by 4.99% to 0.46 in 2024, then rose by 24.36% to 0.57 in 2025, then increased by 4.81% to 0.59 in 2026.
  • Business Quant data shows Asset Utilization Ratio for PCRX at 0.59 in Q1 2026, 0.57 in Q4 2025, and 0.51 in Q3 2025.